✦ LIBER ✦

Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach

✍ Scribed by L. Xu; C. Dalla Man; B. Charbonnel; G. Meninger; M. J. Davies; D. Williams-Herman; C. Cobelli; P. P. Stein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of adding sitagliptin, a dipeptid

✍ R. Brazg; L. Xu; C. Dalla Man; C. Cobelli; K. Thomas; P. P. Stein 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Efficacy and safety of the dipeptidyl pe

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Efficacy and safety of the dipeptidyl pe

✍ M. A. Nauck; G. Meininger; D. Sheng; L. Terranella; P. P. Stein; Sitagliptin Stu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Cost-effectiveness of sitagliptin-based

✍ B. Schwarz; M. Gouveia; J. Chen; G. Nocea; K. Jameson; J. Cook; G. Krishnarajah; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

Effect of linagliptin monotherapy on gly

✍ S. Del Prato; A. H. Barnett; H. Huisman; D. Neubacher; H.-J. Woerle; K. A. Dugi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

Early and longer term effects of gastric

✍ S. Camastra; A. Gastaldelli; A. Mari; S. Bonuccelli; G. Scartabelli; S. Frascerr 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 324 KB